⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21603101 | 0.80 | — | — | |
| SCHEMBL565453 | 0.68 | — | — | |
| SCHEMBL19183339 | 0.68 | — | — | |
| SCHEMBL7461536 | 0.67 | — | — | |
| SCHEMBL9876093 | 0.64 | — | — | |
| SCHEMBL21603075 | 0.64 | — | — | |
| SCHEMBL11026748 | 0.63 | HSD11B1 (0.31) | — | |
| SCHEMBL10721940 | 0.62 | — | — | |
| SCHEMBL10726749 | 0.62 | — | — | |
| SCHEMBL21603116 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020004521-A1 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2020-01-02 | — | — | WO | disclosed |